Data from the Michigan Department of Health and Human Services shows a 34% reduction in overdose deaths between 2023 and 2024 ...

Fintel reports that on June 6, 2025, Goldman Sachs initiated coverage of Teva Pharmaceutical Industries Limited - Depositary ...

Current Deferiprone market momentum reflects rising transfusion-related iron overload cases, broader regulatory approvals, generic competition loweri ...

Birth control medication is being pulled from Canadian shelves over extra placebo tablets, Health Canada says. The recall ...

At Teva Pharmaceutical Industries Ltd, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 183.58K shares worth $3.79M, meanwhile ...

Goldman Sachs initiates Teva, Viatris, and Amneal, highlighting branded growth and pipeline strength, but one company's ...

Teva Pharmaceutical (TEVA) stock, Amneal Pharma (AMRX) stock receive Buy ratings and Viatris (VTRS) stock receives a Neutral rating at Goldman Sachs. Read more here.

NORTHAMPTON, MA / ACCESS Newswire / June 6, 2025 / Teva Pharmaceutical:At Teva, we are all in for better health. Increasing access to quality medicines is fundamental to improving the health of patien ...

Huntington’s disease affects an estimated 5 to 10 per 100,000 people in most Western countries, with variation by region and ...

Alvotech is a biotech company, founded by Robert Wessman, focused solely on the development and manufacture of biosimilar ...

The FDA has granted Fast Track designation to TEV-53408, an investigational anti-interleukin-15 antibody, for the treatment of celiac disease.